|
|
| Amorfix Life Sciences is a theranostics company dedicated to becoming the world leader in the diagnosis and treatment of Aggregated Misfolded Protein (AMP) diseases of the brain. |
 |
|
|
The Aggregated Misfolded Protein diseases include Transmissible Spongiform Encephalopathies (TSE), such as Bovine Spongiform Encephalopathy (BSE) and the human form variant Creutzfeldt-Jakob Disease (vCJD), as well as degenerative diseases such as Alzheimer's Disease (AD), Amyotrophic Lateral Sclerosis (ALS) and Parkinson's Disease (PD).
June 24, 2008:
Press Release Amorfix Achieves Target Sensitivity with its Alzheimer’s Disease
Diagnostic Test
View the presentation by Dr. George Adams, CEO
at the Rodman & Renshaw 5th Annual Global Healtcare Conference
Click here to launch the webcast
|
|
© Amorfix Life Sciences Ltd.
|
| |
|
|